Clinical Trial Detail

NCT ID NCT03220646
Title The Purpose of This Study is to Test Any Good and Bad Effects of a Study Drug Called Abemaciclib (LY2835219) in Patients With Recurrent Brain Tumors.
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

astrocytoma

oligodendroglioma

meningioma

malignant glioma

central nervous system lymphoma

malignant ependymoma

Therapies

Abemaciclib

Age Groups: adult senior

Additional content available in CKB BOOST